AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys

U.S. drugmaker AbbVie's $63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company is shedding to placate regulators.